University of Maryland School of Medicine logo
Emergency Medicine
All Departments
UMSOM Assistant
UMEM Educational Pearls
  • Home
  • Departments
  • Emergency Medicine
  • CME
  • UMEM Educational Pearls
  • CME
  • Courses and Conferences
  • Free Open Access Medical Education
  • UMEM Educational Pearls

Search

Title: Tuberculosis: Testing and Treatment

Category: International EM

Keywords: Tuberculosis, infectious disease, drug resistance, treatment (PubMed Search)

Posted: 7/15/2015 by Jon Mark Hirshon, MPH, MD, PhD

Tuberculosis (TB) remains a deadly scourge killing approximately 1.5 million each year (see Pearl from 7/2/2105). Recognition by astute clinicians in the emergency department is key, as there is no readily available rapid test.

 

Current testing options:

1) Tuberculin skin test (also known as the Mantoux tuberculin skin test).  A small amount of fluid (tuberculin purified protein derivative) is placed intradermally, usually in the left forearm. A positive test means the person was infected with TB.  (Alternatively, if they grew up outside the US, they could have been vaccinated with Bacillus Calmette–Guérin or BCG.) A positive test is determined by the size of the reaction, but this can vary depending on the patient’s immune status.

 

2) Two interferon-gamma release assays or IGRA blood tests are approved for TB.  While not readily available in all institutions, this is the preferred method for someone vaccinated with BCG.

 

Diagnosis of TB disease is based upon:

  • Medical history
  • Physical exam
  • A positive TB test
  • Chest radiograph
  • Other appropriate laboratory test (such as acid fast bacilli on sputum smear followed by culture)

 

Treatment:

TB treatment depends on the susceptibility of the organism and the immune status of the patient.  For a susceptible organism in a non-HIV patient, the first-line anti-TB agents regimens include

  • isoniazid (INH),
  • rifampin (RIF),
  • ethambutol (EMB), and
  • pyrazinamide (PZA).

 

Typical treatment has an initial phase of 2 months, followed by a choice of several options for the continuation phase of either 4 or 7 months. Further information can be found at the CDC website on tuberculosis

 

Bottom Line

As stated previously, in the emergency department, maintain a strong clinical awareness for tuberculosis for someone with night sweats, cough, chest pain, and intermittent fever lasting for 3 weeks or longer.  In particular, consider this diagnosis for someone from a low- or middle-income country or if he or she is HIV positive.

References

http://www.cdc.gov/tb/topic/testing/default.htm

http://www.cdc.gov/tb/publications/factsheets/testing/diagnosis.htm

http://www.cdc.gov/tb/publications/factsheets/treatment/treatmenthivnegative.htm


University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map